Filing Details
- Accession Number:
- 0000950170-24-094845
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-09 16:48:41
- Reporting Period:
- 2024-08-08
- Accepted Time:
- 2024-08-09 16:48:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1861560 | Nuvalent Inc. | NUVL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1868741 | Ann Deborah Miller | C/O Nuvalent, Inc. One Broadway, 14Th Floor Cambridge MA 02142 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2024-08-08 | 3,000 | $6.89 | 36,300 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2024-08-08 | 112 | $65.66 | 36,188 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2024-08-08 | 624 | $67.17 | 35,564 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2024-08-08 | 96 | $67.95 | 35,468 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2024-08-08 | 1,794 | $69.34 | 33,674 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2024-08-08 | 374 | $69.95 | 33,300 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (Right to Buy) | Disposition | 2024-08-08 | 3,000 | $0.00 | 3,000 | $6.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
176,608 | 2031-04-29 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2023.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.40 to $66.35, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) of this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.64 to $67.58, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.74 to $68.25, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.74 to $69.73, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.76 to $70.33, inclusive.
- The shares underlying this option vest as follows: 25% of the shares vested on April 15, 2022, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.